---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-007640"
form_type: "8-K"
ticker: "BVS"
cik: "0001665988"
company_name: "Bioventus Inc."
filed_at: "2024-01-12T23:59:59+00:00"
generated_at: "2026-06-06T23:56:48.000242+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bioventus accelerates vesting of former Interim CEO Bihl's equity awards upon CEO transition

## Summary
- Board accelerated all outstanding and unvested equity awards of Anthony P. Bihl III effective January 9, 2024.
- Equity awards were originally set to vest in April 2024; acceleration was discretionary under award terms.
- Bihl served as Interim President and CEO since April 2023; Robert E. Claypoole succeeded him on January 10, 2024.
- Acceleration based on Bihl's performance and contributions to the Company.

## SEC filing metadata
- accession: 0001193125-24-007640
- form_type: 8-K
- ticker: BVS
- cik: 0001665988
- company_name: Bioventus Inc.
- filed_at: 2024-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1665988/000119312524007640/0001193125-24-007640-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1665988/000119312524007640/d727616d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-007640
- JSON: https://secwatch.observer/filing/0001193125-24-007640.json
- Plain text: https://secwatch.observer/filing/0001193125-24-007640.txt

## Key facts
- Executive change
  Robert E. Claypoole was appointed as President and Chief Executive Officer at Bioventus Inc..
  - Action: succeeded
  - Role: President and Chief Executive Officer
  source text: As previously reported, Robert E. Claypoole succeeded Mr. Bihl as President and Chief Executive Officer of the Company on January 10, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000119312524007640/0001193125-24-007640-index.htm
- Executive change
  Anthony P. Bihl III departed as Interim President and Chief Executive Officer at Bioventus Inc..
  - Role: Interim President and Chief Executive Officer
  source text: As previously reported, Robert E. Claypoole succeeded Mr. Bihl as President and Chief Executive Officer of the Company on January 10, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000119312524007640/0001193125-24-007640-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.